Travere Therapeutics, Inc. - COMMON STOCK (TVTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
TVTX on Nasdaq
Shares outstanding
90,318,827
Price per share
$38.21
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
100,727,843
Total reported value
$2,407,389,690
% of total 13F portfolios
0%
Share change
-180,662
Value change
+$19,761,132
Number of holders
234
Price from insider filings
$38.21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Travere Therapeutics, Inc. - COMMON STOCK (TVTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 12% -6.9% $253,331,874 -$17,690,876 10,599,660 -6.5% JANUS HENDERSON GROUP PLC 30 Sep 2025
FMR LLC 12% $403,768,185 10,567,303 FMR LLC 31 Dec 2025
ARMISTICE CAPITAL, LLC 7.5% -25% $160,703,600 -$51,337,200 6,724,000 -24% Armistice Capital, LLC 30 Sep 2025
BlackRock, Inc. 7.5% -21% $122,617,344 -$24,357,949 6,689,435 -17% BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 6.7% +18% $88,715,388 +$14,507,892 5,994,283 +20% The Vanguard Group 30 Jun 2025
PERCEPTIVE ADVISORS LLC 5.5% $117,005,198 4,895,615 Perceptive Advisors LLC 06 Oct 2025
MACQUARIE GROUP LTD 5.4% +10% $87,934,766 +$9,857,086 4,797,314 +13% Macquarie Group Limited 31 Mar 2025
Rock Springs Capital Management LP 3.3% -40% $53,545,523 -$37,621,463 2,921,196 -41% Rock Springs Capital Management LP 31 Mar 2025
Woodline Partners LP 2.4% $38,750,646 2,114,056 Woodline Partners LP 31 Dec 2024

As of 30 Sep 2025, 234 institutional investors reported holding 100,727,843 shares of Travere Therapeutics, Inc. - COMMON STOCK (TVTX). This represents 112% of the company’s total 90,318,827 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Travere Therapeutics, Inc. - COMMON STOCK (TVTX) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JANUS HENDERSON GROUP PLC 12% 10,599,660 +11% 0.12% $253,305,508
BlackRock, Inc. 9% 8,100,461 -0.84% 0% $193,601,018
ARMISTICE CAPITAL, LLC 7.4% 6,724,000 -24% 5% $160,703,600
VANGUARD GROUP INC 7.3% 6,613,368 +10% 0% $158,059,496
MACQUARIE GROUP LTD 5.5% 4,984,333 -2.2% 0.14% $119,126,000
PERCEPTIVE ADVISORS LLC 4.2% 3,794,615 +355% 2.7% $90,691,299
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.9% 3,552,000 +28% 0.13% $84,892,800
STATE STREET CORP 3.6% 3,217,839 -7.6% 0% $76,906,352
FMR LLC 3.2% 2,894,148 +171% 0% $69,170,132
Rock Springs Capital Management LP 2.4% 2,164,773 +13% 3% $51,738,075
EMERALD ADVISERS, LLC 2.4% 2,146,767 +2.6% 1.6% $51,307,731
GEODE CAPITAL MANAGEMENT, LLC 2.4% 2,138,030 +6.7% 0% $51,107,077
RENAISSANCE TECHNOLOGIES LLC 1.9% 1,752,114 -30% 0.06% $41,875,525
Stephens Investment Management Group LLC 1.8% 1,599,668 0.5% $38,232,065
DEUTSCHE BANK AG\ 1.8% 1,599,295 +210% 0.01% $38,223,150
Eversept Partners, LP 1.6% 1,417,204 +7.8% 2.6% $33,871,176
BANK OF AMERICA CORP /DE/ 1.5% 1,398,930 -14% 0% $33,434,428
GOLDMAN SACHS GROUP INC 1.4% 1,273,903 -18% 0% $30,446,282
WELLINGTON MANAGEMENT GROUP LLP 1.3% 1,201,469 +3332% 0.01% $28,715,110
EMERALD MUTUAL FUND ADVISERS TRUST 1.3% 1,200,942 +5.2% 1.5% $28,702,514
RA CAPITAL MANAGEMENT, L.P. 1.3% 1,150,000 0% 0.34% $27,485,000
MORGAN STANLEY 1.2% 1,117,036 -29% 0% $26,697,170
JENNISON ASSOCIATES LLC 1.2% 1,084,350 +41% 0.02% $25,915,965
Nuveen, LLC 1.2% 1,078,691 -9.7% 0.01% $25,780,715
Aberdeen Group plc 1.1% 967,385 +7.9% 0.04% $23,120,502

Institutional Holders of Travere Therapeutics, Inc. - COMMON STOCK (TVTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,245,724 $47,584,063 +$2,794,426 $38.21 17
2025 Q3 100,727,843 $2,407,389,690 +$19,761,132 $23.90 234
2025 Q2 100,531,635 $1,487,836,300 +$12,972,115 $14.80 207
2025 Q1 98,007,579 $1,771,747,554 +$87,075,624 $17.92 214
2024 Q4 95,064,656 $1,655,970,325 +$204,069,962 $17.42 194
2024 Q3 82,734,245 $1,157,476,987 -$64,293,173 $13.99 175
2024 Q2 87,955,117 $723,000,948 +$2,540,410 $8.22 168
2024 Q1 87,706,388 $676,170,447 +$11,374,907 $7.71 172
2023 Q4 85,573,515 $769,316,791 +$27,493,568 $8.99 162
2023 Q3 82,430,217 $736,935,857 -$48,196,261 $8.94 166
2023 Q2 82,714,633 $1,270,488,775 -$85,984,898 $15.36 165
2023 Q1 84,151,882 $1,892,538,812 +$263,849,900 $22.49 171
2022 Q4 72,978,794 $1,535,405,782 +$36,464,951 $21.03 153
2022 Q3 69,779,173 $1,719,469,986 -$2,015,044 $24.64 168
2022 Q2 69,489,567 $1,683,983,339 +$17,370,839 $24.23 166
2022 Q1 69,479,485 $1,789,961,946 +$97,223,694 $25.77 166
2021 Q4 65,477,167 $2,032,139,426 +$61,452,684 $31.04 165
2021 Q3 60,858,590 $1,476,104,164 +$4,235,576 $24.25 145
2021 Q2 60,583,594 $883,983,031 -$73,514,650 $14.59 131
2021 Q1 62,621,768 $1,563,390,183 +$254,685,025 $24.97 147
2020 Q4 52,293,956 $1,423,328,983 +$1,416,953,984 $27.26 135